PORTFOLIO NEWS Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes May 25, 2023 Read More » RAPT Therapeutics To Present Biomarker Data Corroborating Demonstrated Clinical Activity and Mechanism of Action of FLX475 in Advanced Cancers May 25, 2023 Read More » eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting May 25, 2023 Read More » RAPT Therapeutics Reports First Quarter 2023 Financial Results May 11, 2023 Read More » Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 10, 2023 Read More » Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates May 10, 2023 Read More » Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction May 10, 2023 Read More » eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 9, 2023 Read More » NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 May 8, 2023 Read More » ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates May 8, 2023 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes May 25, 2023 Read More »
RAPT Therapeutics To Present Biomarker Data Corroborating Demonstrated Clinical Activity and Mechanism of Action of FLX475 in Advanced Cancers May 25, 2023 Read More »
eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting May 25, 2023 Read More »
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 10, 2023 Read More »
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates May 10, 2023 Read More »
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction May 10, 2023 Read More »
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 9, 2023 Read More »
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 May 8, 2023 Read More »
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates May 8, 2023 Read More »
